Search Results - "Bakulina, N V"

Refine Results
  1. 1

    Ruxolitinib versus dexamethasone in hospitalized adults with COVID-19: multicenter matched cohort study by Stanevich, O V, Fomina, D S, Bakulin, I G, Galeev, S I, Bakin, E A, Belash, V A, Kulikov, A N, Lebedeva, A A, Lioznov, D A, Polushin, Yu S, Shlyk, I V, Vorobyev, E A, Vorobyeva, S V, Surovceva, T V, Bakulina, N V, Lysenko, M A, Moiseev, I S

    Published in BMC infectious diseases (22-12-2021)
    “…Several anti-cytokine therapies were tested in the randomized trials in hospitalized patients with severe acute respiratory syndrome coronavirus 2 infection…”
    Get full text
    Journal Article
  2. 2

    The eosinophilic esophagitis and IgG4-related disease involving the esophagus by Bakulina, N V, Simanenkov, V I, Vorobyev, S L, Tikhonov, S V, Lishchuk, N B, Bakulin, I G

    Published in Terapevtic̆eskii arhiv (03-09-2020)
    “…The study of eosinophilic esophagitis has become a dynamic field with an evolving understanding of the pathogenesis, diagnosis, and treatment. Immunoglobulin…”
    Get full text
    Journal Article
  3. 3

    Chronic gastritis and functional dyspepsia. Unity and struggle of two opposites by Bakulina, N. V., Tikhonov, S. V., Lishchuk, N. B.

    Published in Medicinskij sovet (19-10-2021)
    “…The review article describes the epidemiology, clinical picture, pathogenesis, approaches to the diagnosis and treatment of chronic gastritis and functional…”
    Get full text
    Journal Article
  4. 4

    Management of risk factors for gastrointestinal bleeding in patients receiving anticoagulant therapy by Bakulina, N. V., Tikhonov, S. V., Lishchuk, N. B., Karaya, A. B.

    Published in Rossiĭskiĭ kardiologicheskiĭ zhurnal (04-09-2021)
    “…Direct oral anticoagulants (DOACs) are used to prevent and treat thrombosis and thromboembolic events in patients with various diseases. Despite its high…”
    Get full text
    Journal Article
  5. 5

    Gastritis and dyspepsia: 2 names of one problem? Relations between predominant symptom and syndromal characteristics of upper GI disorders: results of a survey of physicians by Bakulina, N. V., Oganesova, I. A., Topalova, Yu. G., Bakulin, I. G.

    Published in Medicinskij sovet (19-10-2021)
    “…Introduction . Chronic gastritis is one of the most common problems in gastroenterology and general medical practice. In this study, we tried to analyze…”
    Get full text
    Journal Article
  6. 6

    A new mutation in the TYMP-gene: clinical and morphological characteristics of a patient with MNGIE syndrome by Bardakov, S. N., Limaev, I. S., Emelin, A. M., Nikitins, V., Presnyakov, E. V., Kurbatov, S. A., Tsygankova, P. G., Tsargush, V. A., Chekmareva, I. A., Kolmakova, E. V., Bakulina, N. V., Deev, R. V.

    Published in Nervno-myshechnye bolezni (13-12-2022)
    “…Mitochondrial neurogastrointestinal encephalomyopathy is an extremely rare (1–9:1 000 000, Orphanet, 2021) multisystem genetic disease caused by mutations in…”
    Get full text
    Journal Article
  7. 7

    Obesity, non-alcoholic fatty liver disease, COVID-19: dangerous liaisons by Tikhonov, S. V., Dekkanova, V. D., Vinnichuk, S. A., Fil, T. S., Bakulina, N. V.

    Published in Medicinskij sovet (13-05-2021)
    “…The pandemic of COVID-19 is changing the usual clinical practice. Most of the drugs used for the etiotropic and pathogenetic therapy of COVID-19 do not have a…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Efficacy of H. pylori eradication depending on genetic polymorphism of CYP2C19, MDR1 and IL-1β by Bakulina, N V, Maev, I V, Savilova, I V, Bakulin, I G, Il'chishina, T A, Zagorodnikova, K A, Murzina, A A, Andreev, D N

    Published in Terapevtic̆eskii arhiv (15-08-2019)
    “…Aim. To evaluate an association of genetic polymorphisms CYP2C19, MDR1, and IL-1β on the eradication rate by 10-day modified therapy in patients with H. pylori…”
    Get full text
    Journal Article
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15

    Esophagoprotective therapy in patients with erosive esophagitis by Bakulina, Natalia V., Tikhonov, Sergey V., Topalova, Yulia G., Ilchishina, Tatyana A., Vasiliev, Roman O.

    Published in Terapevtic̆eskii arhiv (12-10-2022)
    “…Aim. To evaluate the advantages of using combined therapy of proton-pump inhibitors (PPIs) and esophagoprotector in comparison with basic therapy of PPIs for 4…”
    Get full text
    Journal Article
  16. 16

    Diagnostics and treatment of intraductal papillary mucinous pancreas neoplasm by Khatkov, I E, Poroshina, E G, Solovyeva, O I, Tokareva, T P, Vorobyev, S L, Bakulina, N V

    Published in Terapevtic̆eskii arhiv (11-10-2023)
    “…A clinical case of a 71-year-old patient with intraductal papillary mucinous neoplasia (IPMN) is presented. The diagnosis was established using endoscopic…”
    Get full text
    Journal Article
  17. 17
  18. 18

    Pharmacokinetics and pharmacodynamics of rebamipide. New possibilities of therapy: A review by Bakulina, N V, Tikhonov, S V, Okovityi, S V, Lutaenko, E A, Bolshakov, A O, Prikhodko, V A, Nekrasova, A S

    Published in Terapevtic̆eskii arhiv (16-01-2023)
    “…The MedLine database contains 570 publications, including 71 randomized clinical trials and 6 meta-analyses on the rebamipide molecule in 2022. Indications for…”
    Get full text
    Journal Article
  19. 19
  20. 20